Researchers at Department of Internal Medicine Target Nephrology (Economic evaluation of policy options for dialysis in end-stage renal disease…

Insurance Weekly News

Researchers at Department of Internal Medicine Target Nephrology (Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia)

By a News Reporter-Staff News Editor at Insurance Weekly News -- Investigators publish new report on Nephrology. According to news reporting from Bandung, Indonesia, by VerticalNews journalists, research stated, "This study aims to assess the value for money and budget impact of offering hemodialysis (HD) as a first-line treatment, or the HD-first policy, and the peritoneal dialysis (PD) first policy compared to a supportive care option in patients with end-stage renal disease (ESRD) in Indonesia. A Markov model-based economic evaluation was performed using local and international data to quantify the potential costs and health-related outcomes in terms of life years (LYs) and quality-adjusted life years (QALYs)."

Financial supporters for this research include Bill and Melinda Gates Foundation, Access and Delivery Partnership (ADP) Project, Indonesia Ministry of Health, Australia Indonesia Partnership for Health Systems Strengthening, Department for International Development, UK Government, Rockefeller Foundation.

The news correspondents obtained a quote from the research from the Department of Internal Medicine, "Three policy options were compared, i.e., the PD-first policy, HD-first policy, and supportive care. The PD-first policy for ESRD patients resulted in 5.93 life years, equal to the HD-first policy, with a slightly higher QALY gained (4.40 vs 4.34). The total lifetime cost for a patient under the PD-first policy is around 700 million IDR, which is lower than the cost under the HD-first policy, i.e. 735 million IDR per patient. Compared to supportive care, the incremental cost-effectiveness ratio of the PD-first policy is 193 million IDR per QALY, while the HD-first policy resulted in 207 million IDR per QALY. Budget impact analysis indicated that the required budget for the PD-first policy is 43 trillion IDR for 53% coverage and 75 trillion IDR for 100% coverage in five years, which is less than the HD-first policy, i.e. 88 trillion IDR and 166 trillion IDR. The PD-first policy was found to be more cost-effective compared to the HD-first policy."

According to the news reporters, the research concluded: "Budget impact analysis provided evidence on the enormous financial burden for the country if the current practice, where HD dominates PD, continues for the next five years."

For more information on this research see: Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia. Plos One, 2017;12(5):e0177436. (Public Library of Science - www.plos.org; Plos One - www.plosone.org)

Our news journalists report that additional information may be obtained by contacting A.f.i.a.t.i.n., .D.e.p.a.r.t.m.e.n.t. of Internal Medicine, Faculty of Medicine, Universitas Padjajaran, Bandung, Indonesia. Additional authors for this research include L.C. Khoe, E. Kristin, L.S. Masytoh, E. Herlinawaty, P. Werayingyong, M. Nadjib, S. Sastroasmoro and Y. Teerawattananon.

Keywords for this news article include: Asia, Kidney, Bandung, Indonesia, Nephrology, Renal Disease, Health Insurance.